Gap junctions sensitize cancer cells to proteasome inhibitor MG132-induced apoptosis

Cancer Science

Volumn 101, Issue 3, 2010, Pages 713-721

  Huang, Tao ^a   Zhu, Ying ^a   Fang, Xin ^a   Chi, Yuan ^a   Kitamura, Masanori ^a   Yao, Jian ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CONNEXIN 43; FLUFENAMIC ACID; THAPSIGARGIN; TUNICAMYCIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL COUNT; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFICACY; ENDOPLASMIC RETICULUM STRESS; FIBROBLAST; GAP JUNCTION; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; UBIQUITINATION; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CONNEXIN 43; CYSTEINE PROTEINASE INHIBITORS; ENDOPLASMIC RETICULUM; GAP JUNCTIONS; LEUPEPTINS; LLC-PK1 CELLS; MICE; NEOPLASMS; SWINE;

EID: 77949652115     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01421.x     Document Type: Article

References (51)

1. Daviet L, Colland F. Targeting ubiquitin specific proteases for drug discovery. Biochimie 2008, 90:270-83.
2. Adams J. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 2004, 5:417-21.
3. Hideshima T, Richardson P, Chauhan D. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 2001, 61:3071-6.
4. Conticello C, Adamo L, Giuffrida R. Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death. J Clin Endocrinol Metab 2007, 92:1938-42.
5. Cusack JC, Liu R, Houston M. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res 2001, 61:3535-40.
6. Russo SM, Tepper JE, Baldwin AS. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys 2001, 50:183-93.
7. Nawrocki ST, Carew JS, Pino MS. Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res 2005, 65:658-66.
8. Nawrocki ST, Carew JS, Dunner K. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res 2005, 65:510-9.
9. Fribley A, Zeng Q, Wang C-Y. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol Cell Biol 2004, 24:9695-704.
10. Schroder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res 2005, 569:29-63.
11. Kitamura M. Endoplasmic reticulum stress and unfolded protein response in renal pathophysiology: Janus faces. Am J Physiol Renal Physiol 2008, 295:F323-34.
12. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003, 83:1359-400.
13. Yao J, Oite T, Kitamura M. Gap junctional intercellular communication in the juxtaglomerular apparatus. Am J Physiol Renal Physiol 2009, 296:F939-46.
14. Yao J, Zhu Y, Morioka T, Oite T, Kitamura M. Pathophysiological roles of gap junction in glomerular mesangial cells. J Membr Biol 2007, 217:123-30.
15. Chipman JK, Mally A, Edwards GO. Disruption of gap junctions in toxicity and carcinogenicity. Toxicol Sci 2003, 71:146-53.
16. Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli M-L. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 2005, 1719:125-45.
17. King TJ, Bertram JS. Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta 2005, 1719:146-60.
18. McLachlan E, Shao Q, Wang H-l, Langlois S, Laird DW. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res 2006, 66:9886-94.
19. Shao Q, Wang H, McLachlan E, Veitch GIL, Laird DW. Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res 2005, 65:2705-11.
20. Berthoud VM, Minogue PJ, Laing JG, Beyer EC. Pathways for degradation of connexins and gap junctions. Cardiovasc Res 2004, 62:256-67.
21. Laing JG, Beyer EC. The gap junction protein connexin43 is degraded via the ubiquitin proteasome pathway. J Biol Chem 1995, 270:399-403.
22. Musil LS, Le A-CN, VanSlyke JK, Roberts LM. Regulation of connexin degradation as a mechanism to increase gap junction assembly and function. J Biol Chem 2000, 275(25):207-15.
23. Lin JH, Weigel H, Cotrina ML. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1998, 1:494-500.
24. Azzam EI, de Toledo SM, Little JB. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proc Natl Acad Sci U S A 2001, 98:473-8.
25. Andrade-Rozental AF, Rozental R, Hopperstad MG, Wu JK, Vrionis FD, Spray DC. Gap junctions: the " kiss of death" and the " kiss of life" Brain Res Rev 2000, 32:308-15.
26. Hamel W, Magnelli L, Chiarugi VP, Israel MA. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res 1996, 56:2697-702.
27. Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res 2000, 60:3989-99.
28. Hossain MZ, Wilkens LR, Mehta PP, Loewenstein W, Bertram JS. Enhancement of gap junctional communication by retinoids correlates with their ability to inhibit neoplastic transformation. Carcinogenesis 1989, 10:1743-8.
29. Claudia G, Sáez LV, Montoya M, Eugenín E, Alvarez MG. Increased gap junctional intercellular communication is directly related to the anti-tumor effect of all-trans-retinoic acid plus tamoxifen in a human mammary cancer cell line. J Cell Biochem 2003, 89:450-61.
30. Ehrlich HP, Gabbiani G, Meda P. Cell coupling modulates the contraction of fibroblast-populated collagen lattices. J Cell Physiol 2000, 184:86-92.
31. Yao J, Kitamura M, Zhu Y. Synergistic effects of PDGF-BB and cAMP-elevating agents on expression of connexin43 in mesangial cells. Am J Physiol Renal Physiol 2006, 290:F1083-93.
32. Yao J, Hiramatsu N, Zhu Y. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells. J Am Soc Nephrol 2005, 16:58-67.
33. Yokouchi M, Hiramatsu N, Hayakawa K. Atypical, bidirectional regulation of cadmium-induced apoptosis via distinct signaling of unfolded protein response. Cell Death Differ 2007, 14:1467-74.
34. Luker GD, Pica CM, Song J, Luker KE, Piwnica-Worms D. Imaging 26S proteasome activity and inhibition in living mice. Nat Med 2003, 9:969-73.
35. Oyamada Y, Zhou W, Oyamada H, Takamatsu T, Oyamada M. Dominant-negative connexin43-EGFP inhibits calcium-transient synchronization of primary neonatal rat cardiomyocytes. Exp Cell Res 2002, 273:85-94.
36. Qin H, Shao Q, Curtis H. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem 2002, 277(29):132-8.
37. Zhang Y-W, Kaneda M, Morita I. The gap junction-independent tumor-suppressing effect of connexin 43. J Biol Chem 2003, 278:852-6.
38. Gatti R, Belletti S, Orlandini G, Bussolati O, Dall'Asta V, Gazzola GC. Comparison of Annexin V and Calcein-AM as early vital markers of apoptosis in adherent cells by confocal laser microscopy. J Histochem Cytochem 1998, 46:895-900.
39. Nawrocki ST, Carew JS, Pino MS. Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells. Cancer Res 2006, 66:3773-81.
40. VanSlyke JK, Musil LS. Dislocation and degradation from the ER are regulated by cytosolic stress. J Cell Biol 2002, 157:381-94.
41. Thomas T, Jordan K, Simek J. Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration. J Cell Sci 2005, 118:4451-62.
42. Huang RP, Hossain MZ, Huang R, Gano J, Fan Y, Boynton AL. Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int J Cancer 2001, 92:130-8.
43. Huang T, Wan Y, Zhu Y. Downregulation of gap junction expression and function by endoplasmic reticulum stress. J Cell Biochem 2009, 107:973-83.
44. Emanuele S, Calvaruso G, Lauricella M. Apoptosis induced in hepatoblastoma HepG2 cells by the proteasome inhibitor MG132 is associated with hydrogen peroxide production, expression of Bcl-XS and activation of caspase-3. Int J Oncol 2002, 21:857-65.
45. Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH, Weller M. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem 2000, 75:2288-97.
46. Liu X, Yue P, Chen S. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Cancer Res 2007, 67:4981-8.
47. Frank DK, Szymkowiak B, Josifovska-Chopra O, Nakashima T, Kinnally KW. Single-cell microinjection of cytochrome c can result in gap junction-mediated apoptotic cell death of bystander cells in head and neck cancer. Head Neck 2005, 27:794-800.
48. Wang M, Berthoud VM, Beyer EC. Connexin43 increases the sensitivity of prostate cancer cells to TNFα-induced apoptosis. J Cell Sci 2007, 120:320-9.
49. Saez CG, Velasquez L, Montoya M, Eugenin E, Alvarez MG. Increased gap junctional intercellular communication is directly related to the anti-tumor effect of all-trans-retinoic acid plus tamoxifen in a human mammary cancer cell line. J Cell Biochem 2003, 89:450-61.
50. Sato H, Senba H, Virgona N. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells. Mol Carcinog 2007, 46:215-24.
51. Trosko JE, Chang CC. Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer. Mutat Res 2001, 480-481:219-29.